Pre-Market Laggard: Pfizer (PFE)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Pfizer ( PFE) as a pre-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Pfizer as such a stock due to the following factors:

  • PFE has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $738.8 million.
  • PFE traded 20,009 shares today in the pre-market hours as of 9:28 AM.
  • PFE is down 2.8% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in PFE with the Ticky from Trade-Ideas. See the FREE profile for PFE NOW at Trade-Ideas

More details on PFE:

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The stock currently has a dividend yield of 3.2%. PFE has a PE ratio of 24. Currently there are 7 analysts that rate Pfizer a buy, 1 analyst rates it a sell, and 4 rate it a hold.

The average volume for Pfizer has been 26.2 million shares per day over the past 30 days. Pfizer has a market cap of $214.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.92 and a short float of 1.2% with 3.38 days to cover. Shares are up 10.9% year-to-date as of the close of trading on Monday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux